MX2020011713A - Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado. - Google Patents

Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.

Info

Publication number
MX2020011713A
MX2020011713A MX2020011713A MX2020011713A MX2020011713A MX 2020011713 A MX2020011713 A MX 2020011713A MX 2020011713 A MX2020011713 A MX 2020011713A MX 2020011713 A MX2020011713 A MX 2020011713A MX 2020011713 A MX2020011713 A MX 2020011713A
Authority
MX
Mexico
Prior art keywords
products
production
added value
metabolically engineered
engineered organisms
Prior art date
Application number
MX2020011713A
Other languages
English (en)
Inventor
Jo Maertens
Joeri Beauprez
Mey Marjan De
Original Assignee
Inbiose Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inbiose Nv filed Critical Inbiose Nv
Publication of MX2020011713A publication Critical patent/MX2020011713A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2431—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/305—Pyrimidine nucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01007—Sucrose phosphorylase (2.4.1.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01008—Maltose phosphorylase (2.4.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01022—Lactose synthase (2.4.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01069—Galactoside 2-alpha-L-fucosyltransferase (2.4.1.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y504/00—Intramolecular transferases (5.4)
    • C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
    • C12Y504/02002—Phosphoglucomutase (5.4.2.2)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a organismos genéticamente diseñados, especialmente microorganismos tales como bacterias y levaduras, para la producción de bioproductos de valor agregado tal como sacárido especializado, sacárido activado, nucleósido, glicósido, glicolípido o glicoproteína. Más específicamente, la presente invención se refiere a células hospederas que se diseñan metabólicamente de modo que puedan producir los productos especializados valiosos en grandes cantidades y en una tasa alta al evitar los problemas técnicos clásicos que se presentan en los procesos de producción biocatalíticos o fermentativos.
MX2020011713A 2010-07-12 2013-01-11 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado. MX2020011713A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10169304 2010-07-12

Publications (1)

Publication Number Publication Date
MX2020011713A true MX2020011713A (es) 2021-01-08

Family

ID=44060925

Family Applications (7)

Application Number Title Priority Date Filing Date
MX2013000460A MX353506B (es) 2010-07-12 2011-07-12 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011691A MX2020011691A (es) 2010-07-12 2013-01-11 Organismos metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011693A MX2020011693A (es) 2010-07-12 2013-01-11 Organismos metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011714A MX2020011714A (es) 2010-07-12 2013-01-11 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011713A MX2020011713A (es) 2010-07-12 2013-01-11 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011690A MX2020011690A (es) 2010-07-12 2013-01-11 Organismos metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011715A MX2020011715A (es) 2010-07-12 2013-01-11 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
MX2013000460A MX353506B (es) 2010-07-12 2011-07-12 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011691A MX2020011691A (es) 2010-07-12 2013-01-11 Organismos metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011693A MX2020011693A (es) 2010-07-12 2013-01-11 Organismos metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011714A MX2020011714A (es) 2010-07-12 2013-01-11 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2020011690A MX2020011690A (es) 2010-07-12 2013-01-11 Organismos metabolicamente diseñados para la produccion de bio productos de valor agregado.
MX2020011715A MX2020011715A (es) 2010-07-12 2013-01-11 Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.

Country Status (15)

Country Link
US (4) US9701992B2 (es)
EP (3) EP3235907B1 (es)
JP (3) JP5998130B2 (es)
CN (3) CN103025874A (es)
AU (1) AU2011278315B2 (es)
CA (1) CA2804713C (es)
DE (1) DE202011111144U1 (es)
DK (1) DK3235907T3 (es)
ES (1) ES2955617T3 (es)
FI (1) FI3235907T3 (es)
MX (7) MX353506B (es)
MY (1) MY185012A (es)
NZ (1) NZ605093A (es)
SG (2) SG10201504733XA (es)
WO (1) WO2012007481A2 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US9453230B2 (en) * 2011-02-16 2016-09-27 Glycosyn LLC Biosynthesis of human milk oligosaccharides in engineered bacteria
EP3031911B1 (en) 2011-07-12 2018-12-05 Scientist of Fortune S.A. Recombinant microorganism for the production of useful metabolites
US9914947B2 (en) 2011-07-27 2018-03-13 Alliance For Sustainable Energy, Llc Biological production of organic compounds
US20130203136A1 (en) 2011-07-27 2013-08-08 Alliance For Sustainable Energy, Llc Biological production of organic compounds
JP6033632B2 (ja) * 2012-10-15 2016-11-30 国立大学法人 新潟大学 セロビオン酸ホスホリラーゼを用いた酸性βグルコシル二糖の製造方法
US9944965B2 (en) * 2012-12-20 2018-04-17 The Board Of Trustees Of The University Of Illinois Biosynthesis of oligosaccharides
EP3461890A1 (en) * 2014-03-31 2019-04-03 Jennewein Biotechnologie GmbH Total fermentation of oligosaccharides
ES2968677T3 (es) 2014-06-11 2024-05-13 Glycom As Separación de 2’-O-fucosil-lactosa de caldo de fermentación
WO2015197082A1 (en) 2014-06-27 2015-12-30 Glycom A/S Oligosaccharide production
US11926858B2 (en) 2014-06-27 2024-03-12 Glycom A/S Oligosaccharide production
CN104611249B (zh) * 2014-11-17 2019-06-11 中国科学院天津工业生物技术研究所 一种利用醛缩酶全细胞合成d-阿洛酮糖的方法
US10676770B2 (en) 2014-12-16 2020-06-09 Glycom A/S Separation of 2′-FL from a fermentation broth
WO2016153300A1 (ko) * 2015-03-24 2016-09-29 서울대학교 산학협력단 2-푸코실락토오스 생산 변이 미생물 및 이를 이용한 2-푸코실락토오스의 제조방법
BR112018006587A2 (pt) 2015-10-02 2018-10-23 Bonumose Llc produção enzimática de d-tagatose
US10713428B2 (en) 2015-11-02 2020-07-14 Microsoft Technology Licensing, Llc Images associated with cells in spreadsheets
SG11201804996TA (en) * 2015-11-12 2018-07-30 Petiva Private Ltd Food and beverage products comprising low calorie, low glycemic index (gi), and sustained energy release sugar composition
EP3315610B1 (en) 2016-10-29 2020-12-16 Jennewein Biotechnologie GmbH Process for the production of fucosylated oligosaccharides
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
KR20190098246A (ko) 2016-12-27 2019-08-21 인바이오스 엔.브이. 시알일화 화합물의 인 비보 합성
IL305141A (en) * 2017-02-21 2023-10-01 Univ Duke Preparations and methods for robust dynamic metabolic control
WO2018165077A1 (en) 2017-03-07 2018-09-13 DePuy Synthes Products, Inc. Bioresorbable exopolysaccharides
US10633682B2 (en) 2017-03-07 2020-04-28 DePuy Synthes Products, Inc. Bioresorbable exopolysaccharides
BR112019018108A2 (pt) 2017-03-13 2022-06-14 Bonumose Llc Produção enzimática de hexoses
AU2019225994A1 (en) * 2018-02-23 2020-08-13 Danisco Us Inc Synthesis of glucan comprising alpha-1,3 glycosidic linkages with phosphorylase enzymes
US20190323053A1 (en) * 2018-04-23 2019-10-24 Dupont Nutrition Biosciences Aps Increasing activity of 2? fucosyllactose transporters endogenous to microbial cells
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3853372A1 (en) 2018-09-21 2021-07-28 Universiteit Gent Method for the production of amino sugar containing products
CN113260624A (zh) 2018-10-18 2021-08-13 巴斯夫欧洲公司 2′-o-岩藻糖基乳糖的晶型ii、其制备方法、包含该物质的营养、化妆品和药物配制物
US20220002773A1 (en) * 2018-12-18 2022-01-06 Inbiose N.V. Production of 3-fucosyllactose and lactose converting alpha-1,3-fucosyltransferase enzymes
EP3702468A1 (en) * 2019-03-01 2020-09-02 Jennewein Biotechnologie GmbH Fermentative production of carbohydrates by microbial cells utilizing a mixed feedstock
CN110241062A (zh) * 2019-06-27 2019-09-17 江南大学 新大肠杆菌表达系统
BR112022000394A2 (pt) 2019-07-19 2022-03-03 Inbiose Nv Produção de fucosilactose em células hospedeiras
CN110452845B (zh) * 2019-08-15 2021-03-02 江南大学 一种产蔗糖磷酸化酶的大肠杆菌
CN110527704B (zh) * 2019-10-31 2020-03-13 烟台华康荣赞生物科技有限公司 一种合成乳-n-二糖的方法
EP3819382A1 (en) * 2019-11-05 2021-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Enzymatic method for preparation of udp-glcnac
CN114829592A (zh) 2019-12-17 2022-07-29 因比奥斯公司 转化乳糖的α-1,2-岩藻糖基转移酶
US20230212628A1 (en) 2019-12-18 2023-07-06 Inbiose N.V. Production of Sialylated Oligosaccharide in Host Cells
EP4103685A1 (en) 2020-02-14 2022-12-21 Inbiose N.V. Glycominimized bacterial host cells
KR20220155298A (ko) 2020-02-14 2022-11-22 인바이오스 엔.브이. 숙주 세포에서 글리코실화 생성물의 생산
CN111172174B (zh) * 2020-03-06 2022-02-15 沈阳农业大学 OsUGE3基因在改善水稻性状中的应用
EP3954769A1 (en) 2020-08-10 2022-02-16 Inbiose N.V. Production of oligosaccharide mixtures by a cell
CN115803443A (zh) 2020-07-13 2023-03-14 格礼卡姆股份公司 寡糖的制造
CN116171329A (zh) 2020-08-10 2023-05-26 因比奥斯公司 通过细胞培养或微生物发酵产生的寡糖溶液的纯化方法
ES2966260T3 (es) 2020-08-10 2024-04-19 Inbiose Nv Producción de una mezcla de oligosacáridos neutros no fucosilados por una célula
TW202221130A (zh) 2020-08-10 2022-06-01 比利時商因比奧斯公司 唾液酸化雙醣及/或寡醣的細胞生產
EP4192946A1 (en) 2020-08-10 2023-06-14 Inbiose N.V. Cellular production of di- and/or oligosaccharides
EP4192973A2 (en) 2020-08-10 2023-06-14 Inbiose N.V. Production of galactosylated di- and oligosaccharides
CN116171328A (zh) 2020-08-10 2023-05-26 因比奥斯公司 藉由细胞培养或微生物发酵产生的不同寡糖的纯化混合物的制造方法
JPWO2022124302A1 (es) * 2020-12-08 2022-06-16
EP4263816A1 (en) 2020-12-18 2023-10-25 Inbiose N.V. Variant sucrose permease polypeptides
WO2022152914A1 (en) 2021-01-18 2022-07-21 Inbiose N.V. Cellular production of glycosylated products
AU2022210808A1 (en) 2021-01-20 2023-08-31 Inbiose N.V. Production of oligosaccharides comprising ln3 as core structure in host cells
CN117222736A (zh) 2021-04-16 2023-12-12 因比奥斯公司 生物产物的细胞生产
CN117157394A (zh) 2021-04-16 2023-12-01 因比奥斯公司 发酵生产
WO2022219188A1 (en) 2021-04-16 2022-10-20 Inbiose N.V. Cellular production of sialylated di- and/or oligosaccharides
CN117321071A (zh) * 2021-05-17 2023-12-29 帝斯曼知识产权资产管理有限公司 表达转化酶/蔗糖水解酶的微生物菌株
JP2024516207A (ja) 2021-05-17 2024-04-12 ディーエスエム アイピー アセッツ ビー．ブイ． インベルターゼ／スクロースヒドロラーゼを発現する微生物株
CN113265434B (zh) * 2021-05-19 2023-05-02 吉林大学 一种合成udp-半乳糖及合成半乳糖基化合物的方法
EP4370664A1 (en) 2021-07-16 2024-05-22 Inbiose N.V. Lacto-n-biose converting fucosyltransferases
WO2023000243A1 (zh) * 2021-07-22 2023-01-26 深圳先进技术研究院 重组酵母生物转化生产葡萄糖的方法
WO2023034973A1 (en) * 2021-09-02 2023-03-09 Amyris, Inc. Methods of producing human milk oligosaccharides and compositions thereof
WO2023110994A1 (en) 2021-12-14 2023-06-22 Inbiose N.V. Production of alpha-1,4-fucosylated compounds
WO2023110995A1 (en) 2021-12-14 2023-06-22 Inbiose N.V. Production of alpha-1,3-fucosylated compounds
CN114645070B (zh) * 2022-02-28 2022-12-20 北京焉支山科技有限公司 一种己糖-6-磷酸组合物的制备方法及其在化妆品中的应用
BR102022004731A2 (pt) * 2022-03-15 2023-09-26 Yessinergy Holding S/A Processo para produção e purificação de frutooligossacarídeos, produto obtido por tal processo
WO2024017987A1 (en) 2022-07-20 2024-01-25 Inbiose N.V. Production of oligosaccharides in host cells
CN116948928A (zh) * 2023-06-02 2023-10-27 虹摹生物科技(上海)有限公司 种子培养基及无抗生素、无iptg诱导剂的2’-岩藻糖基乳糖的发酵生产方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716837A (en) 1995-02-10 1998-02-10 Monsanto Company Expression of sucrose phosphorylase in plants
CN1258599C (zh) * 1996-09-17 2006-06-07 协和发酵工业株式会社 糖核苷酸类及复合糖类的制备方法
WO1998021339A1 (en) 1996-11-13 1998-05-22 E.I. Du Pont De Nemours And Company Method for the production of 1,3-propanediol by recombinant organisms
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
JP2001546898A (en) 1999-12-21 2003-06-10 Kyowa Hakko Kogyo Kk MODIFIED alpha -1,2-FUCOSYLTRANSFERASE GENE AND PROCESS FOR PRODUCING alpha -1,2-FUCOSYLTRANSFERASE AND FUCOSE-CONTAINING SUGAR CHAIN
US20040058418A1 (en) 2000-04-11 2004-03-25 Tetsuo Endo Alpha 1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate
DE60230971D1 (de) * 2001-04-04 2009-03-12 Genencor Int Entkoppelte anabole und katabole stoffwechselwege in wirtszellen
CA2458512A1 (en) 2001-08-24 2003-03-06 Kyowa Hakko Kogyo Co., Ltd. .alpha.-1,2-fucosyl transferase and dna encoding the same
AU2003902253A0 (en) * 2003-05-12 2003-05-29 The University Of Queensland Method for increasing product yield
DK1661985T3 (en) * 2003-09-04 2018-01-08 Ezaki Glico Co PROCEDURE FOR PREPARING HEAT STABLE SUCROSE PHOSPHORYLASE (SP)
AU2004293810B2 (en) * 2003-11-19 2010-07-01 Pelican Technology Holdings, Inc. Improved protein expression systems
US7422880B2 (en) 2005-01-19 2008-09-09 Ajinomoto Co., Inc. Method for producing an l-amino acid using a bacterium of the enterobacteriaceae family having a pathway of glycogen biosynthesis disrupted
US20080274526A1 (en) * 2007-05-02 2008-11-06 Bramucci Michael G Method for the production of isobutanol
NZ566406A (en) 2005-10-26 2012-04-27 Butamax Advanced Biofuels Llc Fermentive production of four carbon alcohols
MY148510A (en) * 2006-03-09 2013-04-30 Centre Nat Rech Scient Method for producing sialylated oligosaccharides
AT504347B8 (de) 2006-09-21 2008-09-15 Univ Graz Tech Verfahren zur herstellung von glucosederivaten
US8426173B2 (en) 2007-05-02 2013-04-23 Butamax (Tm) Advanced Biofuels Llc Method for the production of 1-butanol
US20110269183A1 (en) * 2007-12-18 2011-11-03 Korea Advanced Institute Of Science And Technology Recombinant microorganism having an ability of using sucrose as a carbon source
ES2563040T3 (es) 2007-12-23 2016-03-10 Gevo, Inc. Organismo de levadura que produce isobutanol a un alto rendimiento
BRPI0907542A2 (pt) * 2008-02-25 2015-07-28 Ajinomoto Kk Método para produzir ácido 5'-guanílico, e, microrganismo com uma capacidade de converter ácido inosínico em ácido 5'-guanílico
WO2010053052A1 (ja) * 2008-11-05 2010-05-14 三井化学株式会社 ２－デオキシ－シロ－イノソース（ｄｏｉ）生産細菌及びこれを用いた２－デオキシ－シロ－イノソース（ｄｏｉ）生産方法
US20110217744A1 (en) * 2008-11-07 2011-09-08 Metabolic Explorer Use of sucrose as substrate for fermentative production of 1,2-propanediol
EP2186904B1 (en) 2008-11-14 2012-07-18 Technische Universität Graz Method for producing glucose derivatives
CA2770842A1 (en) 2009-08-12 2011-02-17 Gevo, Inc. Cytosolic isobutanol pathway localization for the production of isobutanol

Also Published As

Publication number Publication date
MY185012A (en) 2021-04-30
JP2013535962A (ja) 2013-09-19
EP4242320A3 (en) 2023-11-29
JP2017018093A (ja) 2017-01-26
JP6310964B2 (ja) 2018-04-11
US10570430B2 (en) 2020-02-25
US20210017558A1 (en) 2021-01-21
EP3235907A1 (en) 2017-10-25
US11384374B2 (en) 2022-07-12
MX2020011714A (es) 2021-01-08
MX2020011715A (es) 2021-01-08
SG10201504733XA (en) 2015-07-30
MX353506B (es) 2018-01-17
NZ605093A (en) 2014-05-30
CN103025874A (zh) 2013-04-03
CA2804713C (en) 2021-04-27
FI3235907T3 (fi) 2023-09-15
AU2011278315B2 (en) 2015-05-28
WO2012007481A2 (en) 2012-01-19
JP2018121641A (ja) 2018-08-09
JP6599498B2 (ja) 2019-10-30
EP2593549A2 (en) 2013-05-22
MX2013000460A (es) 2013-06-03
SG186836A1 (en) 2013-02-28
EP4242320A2 (en) 2023-09-13
DE202011111144U1 (de) 2021-02-10
ES2955617T3 (es) 2023-12-04
WO2012007481A3 (en) 2012-03-15
US20200140908A1 (en) 2020-05-07
MX2020011690A (es) 2020-12-10
EP3235907B1 (en) 2023-06-21
AU2011278315A1 (en) 2013-01-24
MX2020011691A (es) 2020-12-10
US9701992B2 (en) 2017-07-11
CN107603935A (zh) 2018-01-19
DK3235907T3 (da) 2023-09-18
US20130122553A1 (en) 2013-05-16
CN113736721A (zh) 2021-12-03
CA2804713A1 (en) 2012-01-19
MX2020011693A (es) 2020-12-10
US20170016038A1 (en) 2017-01-19
JP5998130B2 (ja) 2016-09-28

Similar Documents

Publication Publication Date Title
MX2020011714A (es) Organismo metabolicamente diseñados para la produccion de bio productos de valor agregado.
WO2013115659A3 (en) Recombinant microorganisms and methods of use thereof
MX353581B (es) Procesos para producir productos de fermentacion.
NZ701895A (en) Strains of lactobacillus with antifungal properties
HK1203208A1 (en) Mutant microorganisms to synthesize colanic acid, mannosylated and or fucosylated oligosaccharides
WO2012047733A3 (en) Treatment of acne by conditioned media
EP4269584A3 (en) Selective antisense compounds and uses thereof
MX2009007632A (es) Precipitacion de polielectrolito y purificacion de proteinas.
MX2019004568A (es) Produccion mejorada de derivados de acidos grasos.
WO2012173659A3 (en) Lignocellulosic hydrolysates as feedstocks for isobutanol fermentation
MY157111A (en) Recombinant microorganisms and methods of production thereof
AU2012353654A8 (en) Modified microorganisms and methods of making butadiene using same
AU2018271755A1 (en) Method for culturing natural killer cell, using transformed T cell
EA201390790A1 (ru) Переработка биомассы
MX2015005797A (es) Produccion de vacuna recombinante en e.coli mediante conjugacion enzimatica.
WO2015031441A3 (en) Microorganisms engineered to use unconventional sources of phosphorus or sulfur
MY178338A (en) Compositions and methods for biological production of lactate from c1 compounds using lactate dehydrogenase transformants
MY182946A (en) Production of organic acids by fermentation at low ph
NZ701896A (en) Strains of propionibacterium
WO2013128274A3 (en) Recombinant microorganisms and uses thereof
WO2014052923A3 (en) Trophic conversion of photoautotrophic bacteria for improved diurnal properties
GB201009882D0 (en) Yeast strains modified in their sophorolipid production and uses thereof
WO2009120806A3 (en) Expression of oxidoreductases to increase volumetric productivity
WO2013026886A3 (en) Microorganisms of the species bacteroides xylanisolvens
WO2014117084A3 (en) Recombinant synthesis of alkanes